Presenter:

Ron Jankowski
Vice President of Scientific Affairs, Cook MyoSite

Cell Therapy: From Research to Reality

What if we could harness the body's natural ability to heal itself? Learn how a Pittsburgh-based company is leading the world in turning personalized, regenerative medicine from research into reality. On Aug. 5, join Ron Jankowski, PhD, Vice President of Scientific Affairs at Cook MyoSite Inc., as he discusses the concept of regenerative medicine, what it means for the future of healthcare, and how some companies are offering look-a-like treatments without FDA approval. 

Cook MyoSite's technology is based off research conducted during the late 1990s, when a lab at the University of Pittsburgh discovered that a specific type of skeletal muscle cell was responsible for regeneration and regrowth. In 2002, Cook MyoSite was officially formed from that discovery and has since been dedicated to the research and development of technology related to human skeletal muscle cells for the treatment of a variety of disorders.

In the late 1990s, a lab at the University of Pittsburgh discovered that a specific type of skeletal muscle cell was responsible for regeneration and regrowth. It was this discovery that led to the establishment of Cook MyoSite in 2002. Since then, Cook MyoSite has been dedicated to the research and development of technology related to human skeletal muscle cells for the treatment of a variety of disorders.

Ron Jankowski has been with Cook MyoSite since its founding and has more than 15 years’ experience in translational medical and biologic product development. He earned his bachelor’s degree in chemical engineering, master’s degree in bioengineering, and doctoral degree in bioengineering from the University of Pittsburgh. Ron has authored and coauthored numerous peer-reviewed manuscripts, reviews, book chapters, and abstracts involving a wide variety of cellular-based applications. He leads the development programs for current products, investigates new indications for existing products, and evaluates the formation of strategic research partnerships to expand the Cook MyoSite product pipeline with a focus on translational research.  Ron is also actively involved in community promotion of innovation and entrepreneurism.